Robert Spurr - 02 Mar 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role: U.S. President-Pharma Business
Signature: /s/ Debra E. Levin, attorney-in-fact for Robert A. Spurr
Issuer symbol: BHC
Transactions as of: 02 Mar 2022
Net transactions value: +$823,829
Form type: 4
Filing time: 04 Mar 2022, 15:09:01 UTC
Previous filing: 02 Mar 2022
Next filing: 07 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHC	Common Shares, No Par Value	Sale	$37,275	-1,595	-2.4%	$23.37	65,394	02 Mar 2022	Direct	F1
transaction	BHC	Common Shares, No Par Value	Award	$861,105	+35,627	+54%	$24.17	101,021	02 Mar 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BHC	Non-Qualified Stock Options (right to purchase)	Award	$0	+131,910		$0.000000	131,910	02 Mar 2022	Common Shares, No Par Value	131,910	$24.17	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.
F2	Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
F3	The options vest in equal installments on each of the first three anniversaries of the date of grant.